Physician profile
Erin E Koppelman
NPI 1235500588
$910.03
in general payments reported to CMS, 2019-2025
15 companies · $36.41 in 2025
The $36.41 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $332 · 2022: $444 · 2023: $81.03 · 2024: $16.90 · 2025: $36.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $134.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $177.07 | 2021-2023 | Xtandi |
| Teleflex LLC | $119.04 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $98.40 | 2021-2023 | |
| Allergan, INC. | $97.48 | 2021-2022 | |
| Medtronic, INC. | $86.79 | 2022 | |
| Abbvie INC. | $68.07 | 2022 | |
| Coloplast Corp | $49.35 | 2022-2024 | Speedicath |
| Myovant Sciences INC. | $43.22 | 2022 | |
| Amgen INC. | $38.19 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $36.41 | 2025 | Provenge |
| Palette Life Sciences, INC. | $24.21 | 2022 | |
| Urogen Pharma, INC. | $20.48 | 2022 | |
| Sumitomo Pharma America, INC. | $19.42 | 2023 | Gemtesa |
| Smith+Nephew, INC. | $16.80 | 2022 | |
| Axonics, INC. | $15.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Koppelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.